Analysis of Breathing Pattern Post COVID-19
Launched by SHIRLEY LIMA CAMPOS · Dec 20, 2022
Trial Information
Current as of January 17, 2025
Unknown status
Keywords
ClinConnect Summary
This clinical trial, titled "Analysis of Breathing Pattern Post COVID-19," is studying how COVID-19 affects people’s breathing patterns after they have recovered from the virus. Researchers want to understand how different factors, like lung function and muscle strength, relate to breathing changes in individuals who have had COVID-19. To do this, they will use a special device called the Respiratory Diagnostic Assistant (RDA) to measure participants' breathing patterns. The study will follow participants for six months to gather important data that can help improve care for people recovering from COVID-19.
To participate in this study, you must be over 18 years old and have been diagnosed with COVID-19 but are now symptom-free for more than 40 days after your home isolation or hospital discharge. Unfortunately, individuals who are pregnant, unable to complete the assessments, or have had a reinfection with COVID-19 cannot participate. During the study, you can expect to have a clinical interview and a thorough evaluation of your breathing and lung function, all conducted in a friendly and supportive environment at the Federal University of Pernambuco. This research aims to provide better treatment plans for individuals affected by COVID-19, helping to enhance their recovery experience.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older than 18 years;
- • Diagnosed with COVID-19;
- • After the period of home isolation or hospital discharge;
- • More than 40 days without the presence of symptoms associated with COVID-19;
- Exclusion Criteria:
- • Participants who are unable to perform the assessment tests or who present contraindications to the assessment of respiratory function;
- • Those patients who prove reinfection by the new Coronavirus;
- • Pregnant patients;
- • Refusal to sign the Free and Informed Consent Form (FICF)
Trial Officials
Shirley L Campos, Phd
Study Director
Universidade Federal de Pernambuco
About Shirley Lima Campos
Shirley Lima Campos is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapeutic interventions, Ms. Campos leads initiatives that prioritize ethical practices and rigorous scientific standards. Her extensive experience in clinical development, combined with a collaborative approach to partnerships, ensures the successful execution of trials that address unmet medical needs. Passionate about enhancing healthcare through evidence-based solutions, she aims to contribute significantly to the field of clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Recife, Pe, Brazil
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials